Spotlight Asset Group’s Bristol-Myers Squibb BMY Stock Holding History

Spotlight Asset Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$826K	Hold	19,900	–	–	0.58%	33
2024 Q1	$1.08M	Buy	19,900 +450	+2%	+$22.9K	0.77%	26
2023 Q4	$1.13M	Hold	19,450	–	–	1.02%	20
2023 Q3	$1.13M	Hold	19,450	–	–	1.02%	20
2023 Q2	$1.24M	Sell	19,450 -430	-2%	-$28.8K	1.11%	20
2023 Q1	$1.44M	Buy	+19,880	New	+$1.4M	1.43%	19
2022 Q3	$1.44M	Buy	+19,880	New	+$1.44M	1.43%	19
2021 Q3	$1.18M	Buy	19,950 +50	+0.3%	+$3.29K	0.59%	37
2021 Q2	$1.33M	Hold	19,900	–	–	0.51%	39
2021 Q1	$1.26M	Buy	19,900 +250	+1%	+$15.6K	0.47%	41
2020 Q4	$1.22M	Hold	19,650	–	–	0.45%	40
2020 Q3	$1.19M	Sell	19,650 -100	-0.5%	-$6.02K	0.47%	37
2020 Q2	$1.16M	Hold	19,750	–	–	0.49%	35
2020 Q1	$1.1M	Hold	19,750	–	–	0.59%	31
2019 Q4	$1.16M	Buy	+19,750	New	+$1.13M	0.56%	36

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spotlight Asset Group's BMY Position: Q2 2024 in Review

Spotlight Asset Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2024 at 19,900 shares worth $826K. The position accounts for 0.58% of the portfolio, ranked #33.

Spotlight Asset Group first reported a position in BMY in Q4 2019 and has held it in 15 quarters since. The position peaked at $1.44M in Q1 2023. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Spotlight Asset Group held 19,900 shares of Bristol-Myers Squibb worth $826K as of Q2 2024.
Spotlight Asset Group left its Bristol-Myers Squibb share count unchanged in Q2 2024.
Bristol-Myers Squibb made up 0.58% of Spotlight Asset Group's portfolio in Q2 2024, its #33 holding.
Spotlight Asset Group first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 15 quarters since.
Spotlight Asset Group's Bristol-Myers Squibb position peaked at $1.44M in Q1 2023.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.